November 24, 2025
Dr Reddy’s gets marketing authorisation for biosimilar from European Commission
Neutral
The Hindu Business Line
Owner: The Kasturi Family
AI-Powered Biomarker Discovery: From Screening to Translational Insights
Indeterminate
BioPharma Dive
Owner: Informa PLC
Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA
Indeterminate
BioPharma Dive
Owner: Informa PLC
November 26, 2025
Germany’s NIS2 Law: One step away from taking effect
Neutral
JD Supra - California
Owner: Aviva Cuyler
November 26, 2025
These 8 Nations Provide Free Or Low-Cost Language Courses To Newcomers
Indeterminate
Travelbinger
Owner: Jimmy Im
Biosimilar push: Dr Reddy’s gets EU nod for denosumab copy; Prolia, Xgeva rivals set for rollout
Indeterminate
The Times of India
Owner: Sahu Jain Family
November 23, 2025
Merck bags European Commission nod for subcutaneous administration of Keytruda for all adult indications approved in EU
Indeterminate
Medical Dialogues
Owner: Meghna A. Singhania & Prem Aggarwal
Maison Margiela chief executive Gaetano Sciuto on the brand's Dubai plans
Pro-Government
The National News
Owner: United Arab Emirates Government
A history of the monarchy standing up for life
Indeterminate
The Catholic Herald
Việt Nam, EFTA launch 18th round of FTA talks in Đà Nẵng
Indeterminate
Vietnam News Agency
Owner: Vietnamese Government
November 26, 2025
Bristol Myers Squibb Breyanzi secures European Commission nod for Mantle Cell Lymphoma
Indeterminate
Medical Dialogues
Owner: Meghna A. Singhania & Prem Aggarwal
November 26, 2025
Vietnam, EFTA working on 18th FTA negotiation round in Da Nang
Indeterminate
VietnamPlus
Owner: Vietnamese government
From Strategy to Delivery: How Procurement-Led CAPEX Transformation Drives Results
Indeterminate
CFO Dive
Owner: Informa PLC
Bristol Myers Squibb gets EC nod to expand use of Breyanzi for relapsed or refractory mantle cell lymphoma
Neutral
Pharmabiz.com
Owner: P. A. Francis
November 25, 2025
Dr. Reddy’s Laboratories shares jump over 1% as European Commission approves biosimilar AVT03
Center-right
The Economic Times
Owner: Sahu Jain Family
November 25, 2025
Do I need a Temporary Resident Visa or Temporary Resident Permit to enter Canada?
Indeterminate
CIC News
Owner: David Cohen
Merck announces EC approves SC administration of Keytruda for all adult indications approved in the European Union
Neutral
Pharmabiz.com
Owner: P. A. Francis
Novartis to build manufacturing hub in North Carolina with $771M investment
Indeterminate
Manufacturing Dive
Owner: Informa PLC
Dr. Reddy's receives European Commission Approval for AVT03 (denosumab), a Proposed Biosimilar of Prolia® and Xgeva®
Neutral
Equity Bulls
Owner: Non-transparent
November 24, 2025
Dr. Reddy’s Laboratories receives European Commission approval for AVT03
Neutral
Business Upturn
Owner: Vipul Sipani